# ENDS (ENDometriosis & FuSobacterium) Unveiling the Contribution of Fusobacterium Infection to the Development of Endometriosis

> **NCT06368596** · NA · UNKNOWN · sponsor: **IRCCS Sacro Cuore Don Calabria di Negrar** · enrollment: 845 (estimated)

## Conditions studied

- Endometriosis

## Interventions

- **DIAGNOSTIC_TEST:** Fusobacterium detection

## Key facts

- **NCT ID:** NCT06368596
- **Lead sponsor:** IRCCS Sacro Cuore Don Calabria di Negrar
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04
- **Primary completion:** 2025-10
- **Final completion:** 2025-10
- **Target enrollment:** 845 (ESTIMATED)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06368596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06368596, "ENDS (ENDometriosis & FuSobacterium) Unveiling the Contribution of Fusobacterium Infection to the Development of Endometriosis". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT06368596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*